You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

  • Technology appraisal guidance
  • Reference number: TA238
  • Published:  14 December 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders
02 February 2015
(100.48 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 29 January 2015

Back to top